Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

159.99 -3.10 (-1.90%)
Official Closing Price Updated: 7:00 PM EDT, Sep 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,294,328
Open 159.90
Bid (Size) 152.25 (100)
Ask (Size) 152.50 (100)
Prev. Close 163.09
Today's Range 159.62 - 160.93
52wk Range 121.57 - 170.46
Shares Outstanding N/A
Dividend Yield 2.98%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Novartis, Ionis Tumble On Surprise Flop For Heart Drug ↗
Novartis' Ionis-partnered Lp(a) blocker failed in testing. Both stocks fell. 
Via Investor's Business Daily
News headline image
A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths ↗
Novartis and Bristol Myers pause CAR-T autoimmune trials after patient deaths and severe side effects spark safety concerns. 
Via Benzinga
Topics Death

Performance

YTD
+15.5%
+15.5%
1 Month
+2.0%
+2.0%
3 Month
+9.3%
+9.3%
6 Month
-1.7%
-1.7%
1 Year
+24.3%
+24.3%

More News

Read More
News headline image
The Multiple Sclerosis Drug Race Just Got Hotter After Novartis’ Phase 3 Win ↗
Via Benzinga
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Why Novartis Just Surged 6%, Eyeing A Breakout ↗
Via Investor's Business Daily
Novartis (NYSE:NVS): A Dividend Quality Play for Income Investors ↗
Via Chartmill
Novartis (NYSE:NVS): A Top Dividend Stock with Strong Fundamentals and Sustainable Payouts ↗
Via Chartmill
News headline image
Hear from a prostate cancer patient about the one test more men should ask for
Via NewsUSA
News headline image
VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You? ↗
Via MarketBeat
Topics ETFs
News headline image
Breakfast News: A Conversation With Ionis CEO ↗
Via The Motley Fool
Topics ETFs World Trade
News headline image
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? ↗
Via The Motley Fool
Topics ETFs
News headline image
PPH vs. IYH: Which Healthcare Fund Is the Better Buy? ↗
Via The Motley Fool
Topics ETFs
News headline image
This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem ↗
Via MarketBeat
Topics Artificial Intelligence ETFs Stocks
News headline image
The L.A. Lakers Delivered a 1-Year Return of 25%. These ETFs Have Done Even Better. ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Vanguard Is Bullish on Developed Markets Outside the U.S. -- But How Can You Buy Them? These 2 ETFs Can Help. ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? ↗
Via The Motley Fool
Topics ETFs
News headline image
3 Dividend Stocks to Buy for a Lifetime of Passive Income ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Concentrated Pharma Exposure or Broader Global Healthcare? PPH vs. IXJ ↗
Via The Motley Fool
Topics ETFs
News headline image
Novartis (NVS) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Novartis Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics ETFs Earnings
News headline image
Novartis Q2 2026 Earnings Call Transcript ↗
Via Benzinga
Topics Earnings
News headline image
Novartis Bounds For Buy Point. Why Shares Are On The Rise. ↗
Via Investor's Business Daily
News headline image
Novartis Silences Generic Fears With Blowout Quarter, Packed Pipeline ↗
Via Benzinga
News headline image
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026? ↗
Via The Motley Fool
Topics ETFs
News headline image
This Novartis Drug Could Help Delay Dialysis—FDA Grants Full Approval ↗
Via Benzinga

Frequently Asked Questions

Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 159.99
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 09/04/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.